The Dialysis PATIENTS Demonstration Act

Restricted access

The Dialysis PATIENTS Demonstration Act (DPDA) has been the subject of considerable enthusiasm and controversy within the kidney and transplant communities since its introduction in September 2016. The most recent iteration of the legislation, introduced in the U.S. House of Representatives and Senate by a bipartisan group of lawmakers, has garnered substantial support in both chambers, with 185 House cosponsors and 8 Senate cosponsors at press time. Yet the legislation remains a focal point of division within the broader kidney and transplant communities.

At the most basic level, DPDA proposes a Medicare demonstration project that would test a dialysis-focused integrated